Literature DB >> 10037820

Use of an internal ribosome entry site for bicistronic expression of Cre recombinase or rtTA transactivator.

J Lindeberg1, T Ebendal.   

Abstract

Conditional gene targeting depends on tissue and time specificity of recombination events. Endogenous promoters are often used to drive various transgenic constructs. To avoid the problems associated with reconstituting a specific expression pattern in transgenic animals by this method, we tested the internal ribosome entry site of the encephalomyocarditis virus, to enable linkage of the Cre recombinase or rtTA trans-activator to 3' untranslated ends of endogenous genes. Here we report that these constructs function effectively in COS cells. The data suggest that these cassettes will be appropriate for 3' targeting of mouse genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037820      PMCID: PMC148352          DOI: 10.1093/nar/27.6.1552

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  3 in total

1.  Identification of cryptic putative IRESs within the ORF encoding the nonstructural proteins of the human rhinovirus 16 genome.

Authors:  Bingtian Shi; Qinqin Song; Xiaonuan Luo; Juan Song; Dong Xia; Zhiqiang Xia; Mi Liu; Wenjun Wang; Ruifang Wang; Haijun Du; Jun Han
Journal:  Arch Virol       Date:  2021-10-04       Impact factor: 2.574

2.  IRES-Dependent Translational Control during Virus-Induced Endoplasmic Reticulum Stress and Apoptosis.

Authors:  Paul J Hanson; Huifang M Zhang; Maged Gomaa Hemida; Xin Ye; Ye Qiu; Decheng Yang
Journal:  Front Microbiol       Date:  2012-03-19       Impact factor: 5.640

3.  Specific expression of lacZ and cre recombinase in fetal thymic epithelial cells by multiplex gene targeting at the Foxn1 locus.

Authors:  Julie Gordon; Shiyun Xiao; Bernard Hughes; Dong-ming Su; Samuel P Navarre; Brian G Condie; Nancy R Manley
Journal:  BMC Dev Biol       Date:  2007-06-18       Impact factor: 1.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.